Real-Life Benefit of Omalizumab in Improving Control of Bronchial Asthma During COVID-19 Pandemic
Author:
Publisher
Cureus, Inc.
Subject
Aerospace Engineering
Reference18 articles.
1. Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma;Peters MC;Lancet,2020
2. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program;Moore WC;J Allergy Clin Immunol,2007
3. The cost of persistent asthma in Europe: an international population-based study in adults;Accordini S;Int Arch Allergy Immunol,2013
4. Biomarkers in asthma - interpretation and utility in current asthma management;Leru PM;Curr Respir Med Rev,2021
5. Atopy and lifestyle survey of allergic patients from urban environment in Romania: preliminary data from an interactive qualifying project;Leru PM;Cureus,2021
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A retrospective study regarding the influence of COVID-19 disease on asthma;BMC Pulmonary Medicine;2023-01-17
2. Pandemi Döneminde Omalizumab Tedavisi Alan Hastaların Değerlendirilmesi;Turkish Journal of Pediatric Disease;2022-10-06
3. Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center;Biomedicines;2022-01-18
4. Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy;Biomedicines;2021-12-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3